Gragnano, Felice
Moscarella, Elisabetta
CalabrĂ², Paolo http://orcid.org/0000-0002-5018-830X
Cesaro, Arturo
Pafundi, Pia Clara
Ielasi, Alfonso
Patti, Giuseppe
Cavallari, Ilaria
Antonucci, Emilia
Cirillo, Plinio
Pignatelli, Pasquale
Palareti, Gualtiero
Pelliccia, Francesco
Gaudio, Carlo
Sasso, Ferdinando Carlo
Pengo, Vittorio
Gresele, Paolo
Marcucci, Rossella
Fimiani, Fabio
Vitale, Raffaella Antonia
Schiavo, Alessandra
Conte, Marzia
Di Maio, Dario
Pastori, Daniele
Menichelli, Danilo
Grossi, Guido
Di Serafino, Luigi
Taglialatela, Vittorio
Galiero, Raffaele
Acierno, Carlo
del Pinto, Maurizio
Gugliemini, Giuseppe
,
Article History
Received: 3 May 2020
Accepted: 6 June 2020
First Online: 15 June 2020
Compliance with ethical standards
:
: FG: Research grant from the European Society of Cardiology (ESC). GP: speaker/consultant/advisory board for Amgen, Sanofi, Bayer, Boehringer-Ingelheim, BMS-Pfizer, Daiichi Sankyo, Astra Zeneca, Sigma-Tau, Malesci, PIAM and MSD. IC: speaker for BMS-Pfizer, AstraZeneca, and Boeringher-Ingelheim. Other Authors have no conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The study protocol was approved by the local ethics committees and was conducted in accordance with the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study.
: Informed consent was obtained from all individual participants included in the study.
: All study data are available on request to the principal investigator.
: Statistical analysis plan and data analysis are available on request to the principal investigator.